Access Pharmaceuticals, Inc. (ACCP.OB) Award Seven of Eight Section 48D Grants Totaling $1.5 Million
Access Pharmaceuticals, Inc. announced that it has been awarded seven different government grants, totaling $1.5 million, for the continued development of their biotechnology therapies. The grants are a result of the Patient Protection and Affordable Care Act which was signed into law by President Barrack Obama on March 23rd of this year. The Act, which levels the playing field to some extent for small to mid-size companies, created a new Internal Revenue Code Section 48D and provides some financial relief for companies with new therapies that show significant potential to address areas of unmet medical need, or prevent, detect, or…